Abstract

ABSTRACT Respiratory viruses of human origin infect wild apes across Africa, sometimes lethally. Here we report simultaneous outbreaks of two distinct human respiratory viruses, human metapneumovirus (MPV; Pneumoviridae: Metapneumovirus) and human respirovirus 3 (HRV3; Paramyxoviridae; Respirovirus, formerly known as parainfluenza virus 3), in two chimpanzee (Pan troglodytes schweinfurthii) communities in the same forest in Uganda in December 2016 and January 2017. The viruses were absent before the outbreaks, but each was present in ill chimpanzees from one community during the outbreak period. Clinical signs and gross pathologic changes in affected chimpanzees closely mirrored symptoms and pathology commonly observed in humans for each virus. Epidemiologic modelling showed that MPV and HRV3 were similarly transmissible (R 0 of 1.27 and 1.48, respectively), but MPV caused 12.2% mortality mainly in infants and older chimpanzees, whereas HRV3 caused no direct mortality. These results are consistent with the higher virulence of MPV than HRV3 in humans, although both MPV and HRV3 cause a significant global disease burden. Both viruses clustered phylogenetically within groups of known human variants, with MPV closely related to a lethal 2009 variant from mountain gorillas (Gorilla beringei beringei), suggesting two independent and simultaneous reverse zoonotic origins, either directly from humans or via intermediary hosts. These findings expand our knowledge of human origin viruses threatening wild chimpanzees and suggest that such viruses might be differentiated by their comparative epidemiological dynamics and pathogenicity in wild apes. Our results also caution against assuming common causation in coincident outbreaks.

Highlights

  • Respiratory viruses of human origin have caused disease in wild apes across Sub-Saharan Africa and pose a significant and growing threat to wild ape health and conservation [1,2]

  • Epidemic curves (Figure 1) show that the Ngogo and Kanyawara outbreaks each occurred in a single phase, with most cases occurring in January 2017

  • No chimpanzees at Kanyawara died during the outbreak period, with the exception of a female recovering from disease who died following conspecific aggression

Read more

Summary

Introduction

Respiratory viruses of human origin have caused disease in wild apes across Sub-Saharan Africa and pose a significant and growing threat to wild ape health and conservation [1,2]. Rhinovirus C [10] and coronavirus OC43 [11] of human origin have caused chimpanzee mortality in Uganda and mild respiratory disease in Cote d’Ivoire, respectively. Suitable prevention strategies have included improved hygiene and sanitation [13], reduced human visitation [14] and large-scale vaccination of apes (if effective vaccines someday become available) [15]. Such policies could benefit human public health by reducing zoonotic transmission risk [16,17]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.